Characterization of interaction of calf thymus DNA with gefitinib: Spectroscopic methods and molecular docking

被引:109
作者
Shi, Jie-Hua [1 ,2 ]
Liu, Ting-Ting [1 ]
Jiang, Min [1 ]
Chen, Jun [1 ]
Wang, Qi [1 ]
机构
[1] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310032, Zhejiang, Peoples R China
[2] Zhejiang Univ Technol, State Key Lab Breeding Base Green Chem Synth Tech, Hangzhou 310032, Zhejiang, Peoples R China
关键词
Gefitinib; Calf thymus DNA; Interaction; Spectroscopy; Molecular docking; RANDOMIZED PHASE-II; BINDING INTERACTION; EGFR MUTATIONS; LUNG-CANCER; CIPROFLOXACIN; COMPLEXES; TRIAL; MODE;
D O I
10.1016/j.jphotobiol.2015.03.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding interaction of gefitinib with calf thymus DNA (ct-DNA) under the simulated physiological pH condition was studied employing UV absorption, fluorescence, circular dichroism (CD), viscosity measurement and molecular docking methods. The experimental results revealed that gefitinib preferred to bind to the minor groove of ct-DNA with the binding constant (K-b) of 1.29 x 10(4) L mo1(-1) at 298 K. Base on the signs and magnitudes of the enthalpy change (Delta H-0 = -60.4 kJ mol(-1)) and entropy change (Delta S-0 = -124.7J mol(-1) K-1) in the binding process and the results of molecular docking, it can be concluded that the main interaction forces between gefitinib and ct-DNA in the binding process were van der Waals force and hydrogen bonding interaction. The results of CD experiments revealed that gefitinib did not disturb native B-conformation of ct-DNA. And, the significant change in the conformation of gefitinib in gefitinib-ct-DNA complex was observed from the molecular docking results and the change was close relation with the structure of B-DNA fragments, indicating that the flexibility of gefitinib molecule also plays an important role in the formation of the stable gefitinib-ct-DNA complex. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 41 条
[1]   Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group [J].
Canil, CM ;
Moore, MJ ;
Winquist, E ;
Baetz, T ;
Pollak, M ;
Chi, KN ;
Berry, S ;
Ernst, DS ;
Douglas, L ;
Brundage, M ;
Fisher, B ;
McKenna, A ;
Seymour, L .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) :455-460
[2]   Gefitinib: an adverse effects profile [J].
Cersosimo, Robert J. .
EXPERT OPINION ON DRUG SAFETY, 2006, 5 (03) :469-479
[3]   Synthesis, DNA binding, photo-induced DNA cleavage and cytotoxicity studies of europium(III) complexes [J].
Chen, Gong-Jun ;
Qiao, Xin ;
Tian, Jin-Lei ;
Xu, Jing-Yuan ;
Gu, Wen ;
Liu, Xin ;
Yan, Shi-Ping .
DALTON TRANSACTIONS, 2010, 39 (44) :10637-10643
[4]   Synthesis, DNA interaction and antibacterial activities of La(III) and Gd(III) complexes of Schiff base derived from o-vanillin and lysine [J].
Cheng, Jian-Ping ;
Lin, Qiu-Yue ;
Hu, Rui-Ding ;
Zhu, Wen-Zhong ;
Li, Hua-Qiong ;
Wang, Dong-Hang .
CENTRAL EUROPEAN JOURNAL OF CHEMISTRY, 2009, 7 (01) :105-110
[5]   FDA drug approval summary:: Gefitinib (ZD1839) (Iressa®) tablets [J].
Cohen, MH ;
Williams, GA ;
Sridhara, R ;
Chen, G ;
Pazdur, R .
ONCOLOGIST, 2003, 8 (04) :303-306
[6]  
Foresman J.B., 1996, Exploring Chemistry with Electronic Structure Methods, V2nd, DOI DOI 10.1002/JCC.10189
[7]   Interaction of ciprofloxacin with DNA studied by spectroscopy and voltammetry at MWCNT/DNA modified glassy carbon electrode [J].
Fotouhi, Lida ;
Atoofi, Zeynab ;
Heravi, Majid M. .
TALANTA, 2013, 103 :194-200
[8]  
Frisch M. J., 2004, GAUSSIAN 03 REVISION
[9]   Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J].
Fukuoka, M ;
Yano, S ;
Giaccone, G ;
Tamura, T ;
Nakagawa, K ;
Douillard, JY ;
Nishiwaki, Y ;
Vansteenkiste, J ;
Kudoh, S ;
Rischin, D ;
Eek, R ;
Horai, T ;
Noda, K ;
Takata, I ;
Smit, E ;
Averbuch, S ;
Macleod, A ;
Feyereislova, A ;
Dong, RP ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2237-2246
[10]   ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY - A RAPID ACCESS TO ATOMIC CHARGES [J].
GASTEIGER, J ;
MARSILI, M .
TETRAHEDRON, 1980, 36 (22) :3219-3228